The Efficacy and Safety of Azithromycin in Preventing Bronchopulmonary Dysplasia in Ureaplasma-positive Preterm Infants : Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Asan Medical Center0 个研究点目标入组 56 人开始时间: 待定最近更新: 2020年1月14日

适应症

试验速览

暂无简介。

•? A premature infant born at the Asan Medical Center in Seoul with birth weight less than 1,500 g or less than 32 weeks of gestational age
•? A positive result of ureaplasma test (culture or PCR test in gastric juice or tracheal aspirate and nasopharyngeal aspirate) performed after birth (within 30 minutes to 24 hours)
•? Oxygen partial pressures of 0.4 or more, or ventilator-assisted infant (conventional ventilator, high frequency oscillatory ventilator, synchonized noninvasive positive pressure ventilation, noninvasive positive pressure ventilation, nasal continuous positive airway pressure, bubble continuous positive airway pressure, heated humidified high-flow nasal cannula)
•? Parents who have voluntarily participated in this trial have voluntarily signed their written consent.

•? When accompanied by major congenital anomalies
•? When the collection of specimens for research is impossible due to respiratory failure
•? When there is QT interval extension on ECG (QTc> 450 ms)
•? If it is judged by researchers that it is difficult to carry out the clinical trial

发起方